# BioReason-Pro RL Review: daf-2 (C. elegans)

Source: daf-2-deep-research-bioreason-rl.md

- **Correctness**: 4/5
- **Completeness**: 2/5

## What BioReason got right

BioReason produced a technically strong domain analysis for DAF-2 and correctly identified:
- Receptor L-domain + cysteine-rich domain for ligand binding
- Fibronectin type III / Ig-like fold ectodomain
- Intracellular tyrosine kinase catalytic core with active site
- Single-pass transmembrane receptor topology
- Protein tyrosine kinase activity as core molecular function
- Transmembrane receptor tyrosine kinase signaling pathway as biological process
- Plasma membrane localization

The mechanistic hypothesis about ligand-induced dimerization, trans-autophosphorylation, and SH2/PTB adaptor recruitment is accurate.

## What BioReason missed

| Feature | BioReason | Curated Review |
|---------|-----------|----------------|
| Insulin/IGF-1 receptor identity | "growth factor-like ligands" (vague) | Insulin/IGF-1 receptor ortholog |
| DAF-16/FOXO as key target | Not mentioned | Signals through PI3K/AKT to regulate DAF-16 |
| Longevity regulation | Not mentioned | daf-2 mutants live 2x longer |
| Dauer diapause | Not mentioned | Key regulator of dauer entry |
| AGE-1/PDK-1/AKT cascade | Not mentioned | Core downstream signaling pathway |
| RAS-ERK signaling | Not mentioned | DAF-2 signals through RAS-ERK for oogenesis (PMID:24120884) |
| Glucose homeostasis | Not mentioned | Conserved metabolic function |
| Neuronal expression | Not mentioned | Expressed in neurons, intestine; isoform c in ASER neurons |
| Axonal localization | Not mentioned | IDA evidence for isoform c at synaptic regions |
| Tetrameric complex | Not mentioned | Forms 2-alpha/2-beta receptor complex |
| Fat storage | Not mentioned | daf-2 mutants accumulate fat |
| Pathogen resistance | Not mentioned | daf-2 mutants are pathogen-resistant |
| Cell adhesion over-annotation | Not flagged | FN3 domains do not mean cell adhesion function |

## Failure mode analysis

**Domain analysis is accurate but generic.** BioReason correctly identified DAF-2 as a receptor tyrosine kinase but failed to identify it as an insulin receptor family member, despite the Receptor L-domain and cysteine-rich domain combination being diagnostic for this family. The phrase "growth factor-like ligands" is vague where the curated review specifically identifies insulin/IGF-1 signaling.

The analysis is better for DAF-2 than for transcription factors because the multi-domain receptor architecture provides more structural information to work with. However, all the biology that makes DAF-2 interesting -- the longevity phenotype, dauer regulation, the DAF-16 connection, tissue-specific signaling -- is absent.

Notably, BioReason did not include insulin receptor activity (GO:0005009), which is the most specific and informative MF term for DAF-2.
